site stats

Cytek earnings call

WebMar 1, 2024 · Cytek Biosciences, Inc. (NASDAQ:NASDAQ:CTKB) Q4 and Full Year 2024 Earnings Conference Call February 28, 2024 4:30 PM ETCompany ParticipantsPaul … WebFeb 28, 2024 · The consensus earnings estimate was $0.02 per share on revenue of $50.2 million. Revenue grew 24.3% on a year-over-year basis. Cytek Biosciences (CTKB) reported Quarter December 2024 earnings of $0.03 per share on revenue of $48.3 million. ... Cytek will host a conference call to discuss the fourth quarter 2024 financial results on …

Cytek Biosciences, Inc. (CTKB) Q4 and Full Year 2024 …

WebMar 31, 2024 · Cytek Biosciences, Inc. (CTKB) Q3 2024 Earnings Call Transcript seekingalpha.com - November 12 at 5:06 PM: Cytek Biosciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag finance.yahoo.com - November 11 at 8:08 AM: Cytek Biosciences, Inc. (CTKB) Q3 Earnings Surpass Estimates … WebMar 31, 2024 · Cytek Biosciences now expects full year 2024 revenue to be closer to the high end of the range of $160 million to $168 million. Webcast Information Cytek will host a conference call to discuss the first quarter 2024 financial results on Wednesday, May 11, 2024, at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time. chit chat colour wheel nail collection https://gomeztaxservices.com

Cytek Biosciences, Inc. (CTKB) Q3 2024 Earnings Call Transcript

WebFeb 24, 2024 · Cytek Biosciences has confirmed that its next quarterly earnings report will be published on Tuesday, February 28th, 2024. Cytek Biosciences will be holding an … WebFeb 28, 2024 · Cytek Biosciences, Inc. is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling™ … Search Investor Relations. × Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from … Mar 24, 2024: 144: Filed by "insiders" prior intended sale of restricted stock. Non … Cytek Biosciences Fourth Quarter and Full Year 2024 Earnings Conference Call. … Vera Imper, Ph.D. has served as a member the Cytek Board since December 2024. … The Investor Relations website contains information about Cytek Biosciences's … Cytek was incorporated in Delaware in 2014 under the name Cytoville, Inc. In August … WebView Cytek Biosciences (www.cytekbio.com) location in California, United States , revenue, industry and description. ... Q4 and Full Year 2024 Earnings Call Transcript Cytek Biosciences, Inc. (NASDAQ:NASDAQ:CTKB) Q4 and Full Year 2024 Earnings Conference Call February 28, 2024 4:30 PM ETCompany ParticipantsPaul Goodson – Investor ... graph with infinite solutions

Investor Relations Cytek Biosciences

Category:Transcript : Cytek Biosciences, Inc., Q1 2024 Earnings Call, May 11 ...

Tags:Cytek earnings call

Cytek earnings call

Cytek Biosciences, Inc. Provides Revenue Guidance for the Full …

WebAug 10, 2024 · CTKB Cytek Biosciences Inc Q2 2024 Earnings Call Aug 10, 2024 + Google Calendar + iCal Export Details Date: Aug 10, 2024 Time: 5:00 pm - 6:00 pm Other Ticker Details CTKB Company Name Cytek Biosciences Inc Earnings Call Date 10-08-2024 Time (ET) 05:00 PM Fiscal Quarter Q2 Fiscal Year 2024 Live Webcast URL WebApr 10, 2024 · Get a real-time Cytek Biosciences, Inc. (CTKB) stock price quote with breaking news, financials, statistics, charts and more. ... Q4 Earnings Top Estimates. Cytek Biosciences, Inc. (CTKB) delivered earnings and revenue surprises of 40% and 3.07%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what …

Cytek earnings call

Did you know?

WebMay 11, 2024 · Presentation Operator MessageOperator Thank you for standing by, and welcome to the Cytek Biosciences First Quarter 2024 Earnings Conference Call. … WebMay 11, 2024 · Presentation Operator MessageOperator Thank you for standing by, and welcome to the Cytek Biosciences First Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, today's... April 12, 2024

WebFeb 23, 2024 · Total revenue was $38.9 million for the fourth quarter and $128.0 million for the full year of 2024, representing 27% and 38% increases over the corresponding … WebNov 9, 2024 · Sector news Transcript : Cytek Biosciences, Inc., Q3 2024 Earnings Call, Nov 09, 2024 11/09/2024 04:30pm EDT Welcome to Cytek's Third Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator...

WebFeb 6, 2024 · Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 28, 2024. Feb 07, 2024. Webwww.cytekbio.com Ownership Status Publicly Held Financing Status Formerly VC-backed Primary Industry Other Devices and Supplies Other Industries Other Healthcare Technology Systems Biotechnology Stock Exchange NAS Primary Office 46107 Landing Parkway Fremont, CA 94538-6407 United States +1 (877) 000-0000 Cytek Timeline 2024 2024 …

WebFeb 23, 2024 · Q4 2024 Earnings Conference Call2/23/2024. spk_0: keep pretending but i welcome to the site tech biocides his fourth quarter two thousand twenty one earnings …

WebTARSONS PRODUCTS LIMITED : Nieuws en informatie aandeel TARSONS PRODUCTS LIMITED 543399 Bombay Stock Exchange graph with line of best fitWebApr 13, 2024 · Búsqueda avanzada Conéctate. ¿Olvidó su contraseña? chit chat confessionsWebMay 11, 2024 · CTKB Cytek Biosciences Inc Q2 2024 Earnings Call November 8, 2024 Similar post + Google Calendar + iCal Export Details Date: May 11, 2024 Time: 5:00 pm … chitchat contact uschitchat compatible phonesWebNov 12, 2024 · Cytek Biosciences, Inc. (NASDAQ:NASDAQ:CTKB) Q3 2024 Earnings Conference Call November 9, 2024 4:30 PM ETCompany ParticipantsPaul Goodson - Head, IRWenbin Jiang - President, CEO and... chit chat community centre bruneiWebApr 13, 2024 · RBC Capital Markets is positief over het aandeel met een koopadvies. Voorheen was het koersdoel 579 USD, maar deze is licht aangepast naar 582 USD. 13 april 2024 graph with linear functionWebFeb 28, 2024 · Cytek Biosciences expects full year 2024 revenue in the range of $225 million to $235 million, representing growth of 37% to 43% over full year 2024. This includes approximately $20 million of revenue contribution from the acquisition of Luminex’s Flow Cytometry and Imaging Business, which closed on February 28, 2024. Webcast Information graph with line of best fit maker